Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
第三届监事会第十一次会议决议
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Guangdong Drive Biological Technology Group Co., Ltd. It details the convening and attendance of the meeting, and the approval of the company's 2023 first quarter report. The document does not contain the actual financial data or the full quarterly report itself but rather announces the approval of the quarterly report. The document length is short (746 characters) and it serves as a formal announcement of the meeting resolution and report approval, not the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to corporate governance and report approval.
2023-04-26 Chinese
关于召开2022年年度股东大会通知公告
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2022 Annual General Meeting (AGM) of Guangdong Drive Biological Technology Group Co., Ltd. It includes details about the meeting date, voting methods, agenda items to be discussed (such as the 2022 annual report, financial statements, audit report, and other reports), and procedural information for shareholders. The document does not contain the actual annual report or financial statements but rather serves as an announcement for the AGM and the materials to be reviewed there. The document length is 3112 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-17 Chinese
2022年年度审计报告
Regulatory Filings
2023-04-17 Chinese
独立董事关于第三届董事会第十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various matters discussed at the company's third board of directors' tenth meeting. It includes opinions on the 2022 annual equity distribution plan, reappointment of the 2023 audit firm, a special report on the use of raised funds, a proposal to use idle raised funds for financial products, the 2022 internal control self-assessment report, and the cancellation of certain stock options. The document is not a full annual report or audit report but rather an independent opinion on board meeting matters, including audit-related opinions and proposals to be submitted to the shareholders' meeting. It is a governance-related document reflecting board and independent directors' opinions on corporate governance and financial matters. The document length is short (2026 characters) and contains detailed opinions rather than just announcements. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or opinions from the board or senior management, including independent directors' opinions on board meeting matters.
2023-04-17 Chinese
华安证券股份有限公司关于广东驱动力生物科技集团股份有限公司使用闲置募集资金进行现金管理的核查意见
Regulatory Filings
2023-04-17 Chinese
2022年年度权益分派预案公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as a 2022 annual equity distribution plan announcement by Guangdong Driving Force Biotechnology Group Co., Ltd. It details the company's profit distribution proposal for the year 2022, including cash dividends per share, total dividend amount, and references to the audited 2022 annual report. It also includes board and supervisory committee approvals, independent director opinions, and compliance with company articles and prior commitments. The document focuses on dividend amount, payment plans, and related corporate governance matters. It does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is not a simple announcement of report publication but a substantive announcement of dividend distribution details. Therefore, it fits best under the category of Notice of Dividend Amount (DIV). The document length is 3625 characters, which is sufficient for a detailed dividend announcement but not a full report. Hence, the classification is DIV with high confidence.
2023-04-17 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.